CJC-1295 DAC
CJC-1295 with Drug Affinity Complex binds to albumin, extending the half-life dramatically and maintaining elevated GH and IGF-1 levels for up to two weeks per injection.
Protocol
1–2 mg weekly injection
Half-Life
7–10 days
Molecular Structure & Chemistry
15 residues • 248 atoms • Skeletal Formula
C81H118N24O24S
1,573.82 g/mol
1842.848 Da
5.4
-0.91
-1.43
Amino Acid Sequence
Biological Mechanisms
Sustained GH elevation
Observed in clinical research as a primary mechanism of action for CJC-1295 DAC.
IGF-1 increase
Observed in clinical research as a primary mechanism of action for CJC-1295 DAC.
Muscle growth
Observed in clinical research as a primary mechanism of action for CJC-1295 DAC.
Fat metabolism
Observed in clinical research as a primary mechanism of action for CJC-1295 DAC.
Bone density improvement
Observed in clinical research as a primary mechanism of action for CJC-1295 DAC.
Safety & Risk Analysis
Critical Safety Warning
Black market peptides can be contaminated, mislabeled, or dangerous. Only obtain peptides via a registered doctor and legitimate pharmacy. Never attempt self-administration without professional medical supervision.
Community Journey Log
Log Your Journey
Share your research observations with the community.
Sign in to contribute
Create a free account to log your research journey and share observations with the community.
Community Observations (0)
No journey logs yet. Be the first to share.
This compound is for research purposes only. Clinical applications must be directed by a licensed physician.
View Community Logs